|
⚲
|
| Keyboard |
| King Rachel K
✚
|
|
|---|---|
| CIK # | 0001589712 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001589712] | |
| 4 | [0001589712] | |
| 5 | [0001589712] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| King Rachel K | |
| Fulcrum Therapeutics Inc | |
| Novavax Inc | |
| Crescent Biopharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Fulcrum Therapeutics Inc FULC
Stock Option (right to buy) · derivative
|
2025-06-26 | Grant | 36,000 | $0.00 | |
|
Novavax Inc NVAX
Stock Option (Right to Buy) · derivative
|
2025-06-20 | Grant | 28,326 | $6.42 | 181,853 |
|
Novavax Inc NVAX
Restricted Stock Units · derivative
|
2025-06-20 | Grant | 18,884 | $0.00 | |
|
Novavax Inc NVAX
Common Stock
|
2025-06-12 | Option exercise | 10,420 | $0.00 | |
|
Novavax Inc NVAX
Restricted Stock Units · derivative
|
2025-06-12 | Option exercise | 10,420 | $0.00 | |
|
Novavax Inc NVAX
Common Stock
|
2024-12-13 | Sell | 4,150 | $9.02 | 37,433 |
|
Fulcrum Therapeutics Inc FULC
Stock Option (right to buy) · derivative
|
2024-11-12 | Grant | 60,000 | $0.00 | |
|
Novavax Inc NVAX
Common Stock
|
2024-06-12 | Option exercise | 6,670 | $0.00 | |
|
Novavax Inc NVAX
Stock Option (Right to Buy) · derivative
|
2024-06-12 | Grant | 15,630 | $15.86 | 247,892 |
|
Novavax Inc NVAX
Restricted Stock Units · derivative
|
2024-06-12 | Grant | 10,420 | $0.00 | |
|
Novavax Inc NVAX
Restricted Stock Units · derivative
|
2024-06-12 | Option exercise | 6,670 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Stock Option (right to buy) · derivative
|
2024-05-01 | Grant | 40,000 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2024-03-29 | Grant | 3,334 | $3.00 | 10,002 |
|
Crescent Biopharma Inc GLYC
Common stock
|
2023-12-29 | Grant | 4,238 | $2.36 | 10,002 |
|
Crescent Biopharma Inc GLYC
Common stock
|
2023-09-30 | Grant | 6,667 | $1.50 | 10,000 |
|
Novavax Inc NVAX
Stock Option (Right to Buy) · derivative
|
2023-06-12 | Grant | 7,710 | $0.00 | |
|
Novavax Inc NVAX
Restricted Stock Units · derivative
|
2023-06-12 | Grant | 6,670 | $0.00 | |
|
Novavax Inc NVAX
Common Stock
|
2023-06-10 | Option exercise | 3,100 | ||
|
Novavax Inc NVAX
Restricted Stock Units · derivative
|
2023-06-10 | Option exercise | 3,100 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Stock Option (right to buy) · derivative
|
2023-05-19 | Grant | 35,000 | $0.00 | |
| showing 20 of 60 most recent transactions | |||||